At the heart of Amgen’s commitment to biosimilars is our mission to serve patients. Quality, reliably supplied biosimilars are anticipated to offer more treatment options for patients—and we believe that we bring high-quality science to this new space in health care.
We want to help patients access the medicines they need. With increased availability of lower-cost biosimilars, it should be easier to choose the right medicine at the right time.
